Search

everythinglearnresearchcommunity

for

Search:↓

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Fully regenerating human hair follicles not yet achieved.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The skin and thymus develop similarly to protect and support immunity.

Cells treated with Wnt-10b can grow hair after being transplanted into mice.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

New methods have helped find cells that create other cells in the body.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Blocking interferon-gamma might help treat various autoimmune diseases.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

The we/we wal/wal mice have defects in hair growth and skin layer formation, causing hair loss, useful for understanding alopecia.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Hair follicles and deer antlers regenerate similarly through stem cells and are influenced by hormones and growth factors.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

Hair follicle regeneration is possible but challenging, especially in humans, due to the need for specific cells and a better understanding of how they signal growth.